HSA
TTOO

Hussman Strategic Advisors’s T2 Biosystems, Inc TTOO Stock Holding History

Hussman Strategic Advisors’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-52
Closed -$350K – 316
2020
Q3 		$350K Buy
+52
New +$385K 0.09% 234

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hussman Strategic Advisors's TTOO Position: Q4 2020 in Review

Hussman Strategic Advisors sold out of T2 Biosystems, Inc (TTOO) in Q4 2020, closing a stake of 52 shares — an estimated $350K sold.

Hussman Strategic Advisors first reported a position in TTOO in Q3 2020 and held it in 1 quarter. The position peaked at $350K in Q3 2020. 62 funds tracked by Wall St. Rank hold TTOO as of Q4 2020.

  • Hussman Strategic Advisors reported no remaining T2 Biosystems, Inc position as of Q4 2020 after selling out during the quarter.
  • Hussman Strategic Advisors sold 52 T2 Biosystems, Inc shares in Q4 2020, an estimated $350K.
  • Hussman Strategic Advisors first reported a position in T2 Biosystems, Inc in Q3 2020 and held it in 1 quarter.
  • Hussman Strategic Advisors's T2 Biosystems, Inc position peaked at $350K in Q3 2020.
  • 62 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2020.

Based on Hussman Strategic Advisors's 13F filing for Q4 2020, filed 1 Feb 2021.